Different sensitivity of germinal center B cell-like diffuse large B cell lymphoma cells towards ibrutinib treatment

BACKGROUND: Although rituximab in the combination of CHOP chemotherapy has been widely used as the standard treatment for several kinds of B-cell non-Hodgkin lymphoma (B-NHL), a great number of B-NHL patients treated with this immunotherapy still develop primary and secondary resistance. Recently Br...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Xiaohui, Ding, Ning, Song, Yuqin, Feng, Lixia, Zhu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984027/
https://www.ncbi.nlm.nih.gov/pubmed/24693884
http://dx.doi.org/10.1186/1475-2867-14-32

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984027/
https://www.ncbi.nlm.nih.gov/pubmed/24693884
http://dx.doi.org/10.1186/1475-2867-14-32

Ejemplares similares